Fig. 4From: A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinomaDistributions of Rad-score of disease progression and no-progression groups in training cohort: A RS1. B RS2. Red bars showed points for patients who survived without locoregional recurrence or distant metastasis, while blue bars showed points for those who experienced progression or died.Back to article page